Brent Peter Forester MD
Geriatric Psychiatry
Dr. Frances S. Arkin Chair of Psychiatry, Tufts University School of Medicine Professor, Department of Psychiatry, Tufts University School of Medicine Chief and Chairman, Department of Psychiatry, Tufts Medical Center Co-Physician Executive, Neuroscience and Behavioral Health Service Line, Tufts Medicine
Join to view full profile
800 Washington StreetBoston, MA 02111
Phone+1 617-636-3108
Dr. Forester is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Geriatric Psychiatry, 1996 - 1997
Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1992 - 1996
Geisel School of Medicine at DartmouthClass of 1992
Certifications & Licensure
NH State Medical License 1996 - 2028
MA State Medical License 1994 - 2027
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Geriatric Psychiatry
Clinical Trials
- Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression Start of enrollment: 2018 May 29
Publications & Presentations
PubMed
- Cannabinoid Treatments for Agitation in Alzheimer's Disease.Paul B Rosenberg, Brent P Forester
The American Journal of Geriatric Psychiatry. 2026-09-01 - Understanding and managing agitation in neurocognitive disorders: Recent insights and global perspectives.Debby L Gerritsen, Maarten Van Den Bossche, Alireza Atri, Sanjeda Chumki, Jeffrey Cummings
International Psychogeriatrics. 2026-07-22 - Anticonvulsant Use in Older Age Bipolar Disorder in a Global Sample from the Global Aging and Geriatric Experiments in Bipolar Disorder Project: Utilisation d'anticonv...Katie C Bodenstein, Myriam Lesage, Paola Lavin, Sigfried Schouws, Melis Orhan
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 2026-07-01
Press Mentions
Tufts Medicine Selected to Advance Early Detection of Cognitive Impairment + Alzheimer’s Disease in Primary CareFebruary 9th, 2026
Cannabis Product May Help Ease Agitation of Alzheimer’sOctober 9th, 2024
Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer’s DiseaseOctober 2nd, 2024
Grant Support
- Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimer's DementiaMCLEAN HOSPITAL2020–2025
- A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD)MCLEAN HOSPITAL2018–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
